PARP Inhibition in Prostate Cancer: A Promising Approach

Oncology (Williston Park). 2016 May;30(5):393-4, 485.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Drug Design*
  • Humans
  • Male
  • Poly(ADP-ribose) Polymerase Inhibitors / therapeutic use*
  • Prostatic Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Poly(ADP-ribose) Polymerase Inhibitors